DZ2303A1 - Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. - Google Patents

Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.

Info

Publication number: DZ2303A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; indazole derivatives; derivatives process
Prior art date: 1996-09-04

Application number

DZ970153A

Other languages

English (en)

French (fr)

Inventor

Anthony Marfat

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-04

Filing date

1997-09-03

Publication date

2002-12-28

1997-09-03 Application filed by Pfizer filed Critical Pfizer

2002-12-28 Application granted granted Critical

2002-12-28 Publication of DZ2303A1 publication Critical patent/DZ2303A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Obesity (AREA)
Hematology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
AIDS & HIV (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DZ970153A 1996-09-04 1997-09-03 Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant. DZ2303A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US2544696P	1996-09-04	1996-09-04

Publications (1)

Publication Number	Publication Date
DZ2303A1 true DZ2303A1 (fr)	2002-12-28

Family

ID=21826124

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970153A DZ2303A1 (fr)	1996-09-04	1997-09-03	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.

Country Status (35)

Country	Link
US (1)	US6262040B1 (xx)
EP (1)	EP0931075A1 (xx)
JP (2)	JP3554337B2 (xx)
KR (1)	KR100338610B1 (xx)
CN (1)	CN1234031A (xx)
AP (1)	AP795A (xx)
AR (1)	AR008162A1 (xx)
AU (1)	AU724549B2 (xx)
BG (1)	BG64447B1 (xx)
BR (1)	BR9712005A (xx)
CA (1)	CA2264798A1 (xx)
CO (1)	CO4600636A1 (xx)
DZ (1)	DZ2303A1 (xx)
EA (1)	EA002113B1 (xx)
GT (1)	GT199700102A (xx)
HN (1)	HN1997000126A (xx)
HR (1)	HRP970478B1 (xx)
HU (1)	HUP9903248A3 (xx)
ID (1)	ID18157A (xx)
IL (1)	IL128642A0 (xx)
IS (1)	IS4979A (xx)
MA (1)	MA26439A1 (xx)
NO (1)	NO991048L (xx)
NZ (1)	NZ334213A (xx)
OA (1)	OA10985A (xx)
PA (1)	PA8437301A1 (xx)
PE (1)	PE107998A1 (xx)
PL (1)	PL332187A1 (xx)
SK (1)	SK27299A3 (xx)
TN (1)	TNSN97148A1 (xx)
TR (1)	TR199900481T2 (xx)
TW (1)	TW402595B (xx)
WO (1)	WO1998009961A1 (xx)
YU (1)	YU11299A (xx)
ZA (1)	ZA977903B (xx)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2258728C (en)	1996-06-19	2011-09-27	Rhone Poulenc Rorer Limited	Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
YU25400A (sh) *	1997-11-04	2003-07-07	Pfizer Products Inc.	Terapeutski aktivna jedinjenja sa indazolom
SK6252000A3 (en) *	1997-11-04	2001-11-06	Pfizer Prod Inc	Indazole bioisostere replacement of catechol in therapeutically active compounds
JP2000198734A (ja) *	1998-12-30	2000-07-18	Pfizer Inc	胃運動性減弱および関連疾患の治療のための運動性増強薬
US6191300B1 (en)	1999-04-16	2001-02-20	Eastman Chemical Company	Process for the preparation of cyclopropylacetonitrile
UA71971C2 (en)	1999-06-04	2005-01-17	Agoron Pharmaceuticals Inc	Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
US7141581B2 (en)	1999-07-02	2006-11-28	Agouron Pharmaceuticals, Inc.	Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
PE20010306A1 (es) *	1999-07-02	2001-03-29	Agouron Pharma	Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
TWI262914B (en)	1999-07-02	2006-10-01	Agouron Pharma	Compounds and pharmaceutical compositions for inhibiting protein kinases
SK287231B6 (sk)	1999-08-21	2010-04-07	Nycomed Gmbh	Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora
US6362213B1 (en)	1999-12-23	2002-03-26	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
EP1244649B1 (en) *	1999-12-23	2005-03-02	Icos Corporation	Cyclic amp-specific phosphodiesterase inhibitors
US7217722B2 (en) *	2000-02-01	2007-05-15	Kirin Beer Kabushiki Kaisha	Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
WO2001079198A1 (en)	2000-04-18	2001-10-25	Agouron Pharmaceuticals, Inc.	Pyrazoles for inhibiting protein kinase
US7205320B2 (en)	2001-01-22	2007-04-17	Memory Pharmaceuticals Corp.	Phosphodiesterase 4 inhibitors
US7153871B2 (en)	2001-01-22	2006-12-26	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
ES2427930T3 (es)	2001-05-23	2013-11-04	Mitsubishi Tanabe Pharma Corporation	Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
JP4510384B2 (ja) *	2001-05-23	2010-07-21	田辺三菱製薬株式会社	骨折治癒促進用組成物
TWI221838B (en)	2001-08-09	2004-10-11	Tanabe Seiyaku Co	Pyrazinoisoquinoline compound or naphthalene compound
PE20030701A1 (es)	2001-12-20	2003-08-21	Schering Corp	Compuestos para el tratamiento de trastornos inflamatorios
MY140561A (en)	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
AU2003262187A1 (en) *	2002-04-12	2003-10-27	Celgene Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1525308A4 (en) *	2002-05-30	2006-11-02	Celgene Corp	METHODS OF USING JNK OR MKK INHIBITORS TO MODULATE CELL DIFFERENTIATION AND TREAT MYELOPROLIFERATIVE DISORDERS AND MYELODYSPLASIC SYNDROMES
RU2368604C2 (ru)	2002-07-19	2009-09-27	Мемори Фармасьютиклз Корпорейшн	Ингибиторы фосфодиэстеразы 4, включающие n-замещенные аналоги анилина и дифениламина
HRP20050082A2 (en) *	2002-07-19	2005-06-30	Memory Pharmaceuticals Corporation	6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
US7087625B2 (en)	2002-11-19	2006-08-08	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors
US7109337B2 (en)	2002-12-20	2006-09-19	Pfizer Inc	Pyrimidine derivatives for the treatment of abnormal cell growth
DK1625121T3 (da)	2002-12-20	2010-05-10	Pfizer Prod Inc	Pyrimidinderivater til behandling af abnorm cellevækst
US7135575B2 (en)	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
AU2004226353A1 (en)	2003-04-01	2004-10-14	Laboratoires Serono Sa	Inhibitors of phosphodiesterases in infertility
US7297709B2 (en) *	2003-05-22	2007-11-20	Abbott Laboratories	Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
US20090048255A1 (en) *	2003-07-21	2009-02-19	Schumacher Richard A	Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
JP2005089457A (ja)	2003-09-03	2005-04-07	Yung Shin Pharmaceutical Industry Co Ltd	骨成長を促進するまたは骨吸収を阻害するための薬剤組成物
MY141255A (en) *	2003-12-11	2010-03-31	Memory Pharm Corp	Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
WO2005085248A1 (en)	2004-02-27	2005-09-15	F.Hoffmann-La Roche Ag	Heteroaryl-fused pyrazolo derivatives
WO2005085249A1 (en)	2004-02-27	2005-09-15	F. Hoffmann-La Roche Ag	Fused derivatives of pyrazole
AU2005219518A1 (en)	2004-02-27	2005-09-15	F. Hoffmann-La Roche Ag	Indazole derivatives and pharmaceutical compositions containing them
WO2005111022A1 (en)	2004-05-14	2005-11-24	Pfizer Products Inc.	Pyrimidines derivatives for the treatment of abnormal cell growth
MXPA06011658A (es)	2004-05-14	2006-12-14	Pfizer Prod Inc	Derivados de pirimidina para el tratamiento del crecimiento celular anormal.
BRPI0510963A (pt)	2004-05-14	2007-11-20	Pfizer Prod Inc	derivados pirimidina para o tratamento do crescimento anormal de células
JP2008505969A (ja) *	2004-07-12	2008-02-28	メルク　エンド　カムパニー　インコーポレーテッド	ヒストン脱アセチル化酵素の阻害剤
US7601847B2 (en)	2004-10-26	2009-10-13	Wyeth	Preparation and purification of 4-(indazol-3-yl)phenols
TW200621237A (en)	2004-11-01	2006-07-01	Wyeth Corp	[(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones
WO2006129158A2 (en) *	2005-05-30	2006-12-07	Ranbaxy Laboratories Limited	3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
JP2009506007A (ja)	2005-08-25	2009-02-12	エフ．ホフマン−ラロシュアーゲー	ｐ３８ＭＡＰキナーゼ阻害剤及びその使用方法
WO2007029077A1 (en)	2005-09-05	2007-03-15	Ranbaxy Laboratories Limited	Substituted indazoles as inhibitors of phosphodiesterase type-iv
US7915286B2 (en)	2005-09-16	2011-03-29	Ranbaxy Laboratories Limited	Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2007210073B2 (en)	2006-01-31	2011-10-06	Array Biopharma Inc.	Kinase inhibitors and methods of use thereof
WO2008026687A1 (en)	2006-09-01	2008-03-06	Kyorin Pharmaceutical Co., Ltd.	Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative
AU2007329480A1 (en) *	2006-12-05	2008-06-12	National Chio Tung University	Indazole compounds
HRP20120361T1 (hr)	2007-03-14	2012-05-31	Ranbaxy Laboratories Limited	DERIVATI PIRAZOLO[3,4-b]PIRIDINA KAO INHIBITORI FOSFODIESTERAZE
US20100029689A1 (en) *	2008-07-02	2010-02-04	Memory Pharmaceuticals Corporation	Phosphodiesterase 4 inhibitors
JP2012521429A (ja) *	2009-03-23	2012-09-13	メルク・シャープ・エンド・ドーム・コーポレイション	疼痛治療用のｐ２ｘ３受容体アンタゴニスト
AU2011242711C1 (en) *	2010-04-22	2016-04-21	Janssen Pharmaceutica Nv	Indazole compounds useful as ketohexokinase inhibitors
EP3323820B1 (en)	2011-02-28	2023-05-10	Epizyme, Inc.	Substituted 6,5-fused bicyclic heteroaryl compounds
US9856263B2 (en)	2014-04-28	2018-01-02	Pfizer Inc.	Heteroaromatic compounds and their use as dopamine D1 ligands
BR112019010164A2 (pt) *	2016-11-18	2019-09-17	Merck Sharp & Dohme	composto, composição farmacêutica, uso de um composto, e, método para tratar aterosclerose, esteatose hepática, aterosclerose, diabetes mellitus tipo 2, obesidade, hiperlipidemia ou hipercolesterolemia.
TW202116754A (zh)	2019-07-11	2021-05-01	美商Ｅ斯蓋普生物股份有限公司	作為ｌｒｒｋ２抑制劑之吲唑及氮雜吲唑
GB201910608D0 (en) *	2019-07-24	2019-09-04	Enterprise Therapeutics Ltd	Compounds
CN112694474B (zh) *	2019-10-23	2022-03-18	四川大学	吲唑类衍生物及其制备方法和用途
US20240279828A1 (en) *	2021-05-31	2024-08-22	Genscript Usa Inc.	Electrografted films for dna synthesis
CN116003325B (zh) *	2023-01-09	2025-04-25	南方医科大学	吲唑类化合物或其药学上可接受的盐及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE531433A (xx)	1953-06-17
US4665397A (en)	1983-11-01	1987-05-12	Universal Photonics, Inc.	Apparatus and method for a universal electronic locking system
GB8524157D0 (en) *	1984-10-19	1985-11-06	Ici America Inc	Heterocyclic amides
JPH061350B2 (ja) *	1985-07-26	1994-01-05	コニカ株式会社	ハロゲン化銀写真感光材料
JPS6250751A (ja) *	1985-08-29	1987-03-05	Konishiroku Photo Ind Co Ltd	ハロゲン化銀写真感光材料
GB8609175D0 (en) *	1986-04-15	1986-05-21	Ici America Inc	Heterocyclic carboxamides
ATE144511T1 (de)	1989-02-02	1996-11-15	Yamanouchi Pharma Co Ltd	Tetrahydrobenzimidazol-derivate
EP0527736B1 (de)	1990-05-18	1997-04-16	Hoechst Aktiengesellschaft	Isoxazol-4-carbonsäureamide und hydroxyalkyliden-cyanessigsäureamide, diese verbindungen enthaltende arzneimittel und deren verwendung
US5444038A (en) *	1992-03-09	1995-08-22	Zeneca Limited	Arylindazoles and their use as herbicides
CA2166721C (en) *	1993-07-06	1999-07-27	Allen Jacob Duplantier	Bicyclic tetrahydro pyrazolopyridines
GB9401460D0 (en)	1994-01-26	1994-03-23	Rhone Poulenc Rorer Ltd	Compositions of matter
NZ279689A (en) *	1994-02-17	1997-08-22	American Home Prod	Substituted biphenyl derivatives, preparation and pharmaceutical compositions thereof
WO1995027692A1 (en) *	1994-04-08	1995-10-19	Smithkline Beecham Corporation	Subtituted biphenyl tnf inhibitors
JPH08143525A (ja) *	1994-11-21	1996-06-04	Banyu Pharmaceut Co Ltd	ヒドロキシ安息香酸アミド誘導体を有効成分とする骨疾患の予防・治療剤
WO1997049702A1 (en) *	1996-06-25	1997-12-31	Pfizer Inc.	Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
DE69709493T2 (de) *	1996-06-27	2002-10-31	Pfizer Inc., New York	Substituierte Indazolderivate

1997
- 1997-08-25 US US09/254,346 patent/US6262040B1/en not_active Expired - Fee Related
- 1997-08-25 CN CN97199022A patent/CN1234031A/zh active Pending
- 1997-08-25 NZ NZ334213A patent/NZ334213A/xx unknown
- 1997-08-25 KR KR1019997001779A patent/KR100338610B1/ko not_active Expired - Fee Related
- 1997-08-25 BR BR9712005A patent/BR9712005A/pt not_active Application Discontinuation
- 1997-08-25 HU HU9903248A patent/HUP9903248A3/hu unknown
- 1997-08-25 YU YU11299A patent/YU11299A/sh unknown
- 1997-08-25 JP JP51240998A patent/JP3554337B2/ja not_active Expired - Fee Related
- 1997-08-25 EA EA199900183A patent/EA002113B1/ru not_active IP Right Cessation
- 1997-08-25 AU AU37813/97A patent/AU724549B2/en not_active Ceased
- 1997-08-25 WO PCT/IB1997/001023 patent/WO1998009961A1/en not_active Ceased
- 1997-08-25 CA CA002264798A patent/CA2264798A1/en not_active Abandoned
- 1997-08-25 EP EP97934678A patent/EP0931075A1/en not_active Withdrawn
- 1997-08-25 SK SK272-99A patent/SK27299A3/sk unknown
- 1997-08-25 PL PL97332187A patent/PL332187A1/xx unknown
- 1997-08-25 IL IL12864297A patent/IL128642A0/xx unknown
- 1997-08-25 TR TR1999/00481T patent/TR199900481T2/xx unknown
- 1997-08-29 HN HN1997000126A patent/HN1997000126A/es unknown
- 1997-09-01 TW TW086112518A patent/TW402595B/zh not_active IP Right Cessation
- 1997-09-02 PE PE1997000777A patent/PE107998A1/es not_active Application Discontinuation
- 1997-09-02 AR ARP970104001A patent/AR008162A1/es unknown
- 1997-09-03 GT GT199700102A patent/GT199700102A/es unknown
- 1997-09-03 PA PA19978437301A patent/PA8437301A1/es unknown
- 1997-09-03 ID IDP973065A patent/ID18157A/id unknown
- 1997-09-03 MA MA24783A patent/MA26439A1/fr unknown
- 1997-09-03 DZ DZ970153A patent/DZ2303A1/xx active
- 1997-09-03 TN TNTNSN97148A patent/TNSN97148A1/fr unknown
- 1997-09-03 ZA ZA977903A patent/ZA977903B/xx unknown
- 1997-09-04 AP APAP/P/1997/001080A patent/AP795A/en active
- 1997-09-04 HR HR970478A patent/HRP970478B1/xx not_active IP Right Cessation
- 1997-09-04 CO CO97051473A patent/CO4600636A1/es unknown
1999
- 1999-02-16 IS IS4979A patent/IS4979A/is unknown
- 1999-02-22 BG BG103195A patent/BG64447B1/bg unknown
- 1999-03-01 OA OA9900046A patent/OA10985A/en unknown
- 1999-03-03 NO NO991048A patent/NO991048L/no unknown
2004
- 2004-03-23 JP JP2004083812A patent/JP2004217668A/ja active Pending

Also Published As

Publication number	Publication date
NO991048D0 (no)	1999-03-03
NZ334213A (en)	2000-08-25
CN1234031A (zh)	1999-11-03
WO1998009961A1 (en)	1998-03-12
ID18157A (id)	1998-03-05
HRP970478A2 (en)	1998-08-31
AR008162A1 (es)	1999-12-09
BR9712005A (pt)	1999-08-24
SK27299A3 (en)	2000-10-09
AP795A (en)	1999-12-28
IS4979A (is)	1999-02-16
EP0931075A1 (en)	1999-07-28
AP9701080A0 (en)	1997-10-31
GT199700102A (es)	1999-02-25
PA8437301A1 (es)	1999-12-27
TR199900481T2 (xx)	1999-06-21
OA10985A (en)	2001-11-01
NO991048L (no)	1999-05-03
JP3554337B2 (ja)	2004-08-18
IL128642A0 (en)	2000-01-31
HUP9903248A3 (en)	2000-07-28
JP2004217668A (ja)	2004-08-05
HUP9903248A2 (hu)	2000-04-28
TNSN97148A1 (fr)	2005-03-15
CA2264798A1 (en)	1998-03-12
PE107998A1 (es)	1999-01-30
EA002113B1 (ru)	2001-12-24
EA199900183A1 (ru)	1999-08-26
HN1997000126A (es)	1997-12-26
KR20000068421A (ko)	2000-11-25
JP2000502724A (ja)	2000-03-07
TW402595B (en)	2000-08-21
MA26439A1 (fr)	2004-12-20
KR100338610B1 (ko)	2002-05-27
CO4600636A1 (es)	1998-05-08
US6262040B1 (en)	2001-07-17
AU3781397A (en)	1998-03-26
BG64447B1 (en)	2005-02-28
PL332187A1 (en)	1999-08-30
YU11299A (sh)	2001-07-10
ZA977903B (en)	1999-03-03
HRP970478B1 (en)	2002-10-31
AU724549B2 (en)	2000-09-28
BG103195A (en)	1999-09-30

Publication	Publication Date	Title
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2581A1 (fr)	2003-02-22	Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2666A1 (fr)	2003-03-22	Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2550A1 (fr)	2003-02-08	Dérivés d'azétidinylpropylpipéridine procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2870A1 (fr)	2003-12-15	Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant.
DZ2407A1 (fr)	2003-01-04	Dérivés de sulfonylurée procédé pour leur préparation et compositions pharmaceutiques les contenant
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2360A1 (fr)	2002-12-28	Dérivés de pyrazole procédé pour leur préparation et compositions les contenant
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
CY2537B1 (fr)	2006-06-28	Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2416A1 (fr)	2003-01-04	Dérivés d'acide arylsulfonylhydroxamique procédé pour leur préparation et compositions les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.